| ID | Name | CAS | Data |
MW (g/mol) |
| 38-420-3 |
Silane, [(3,7,11,15-tetramethyl-2-hexadecenyl)oxy]trimethyl-
|
57397-39-4 |
3 | 368.71 |
| 38-562-6 |
Androstane, 3,17-bis[(trimethylsilyl)oxy]-, (3«alpha»,5«alpha»,17«alpha»)-
|
10426-35-4 |
3 | 436.82 |
| 38-659-9 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-propyl-phosphorothioamidate
|
|
3 | 281.69 |
| 38-787-7 |
1H,5H,7H,11H-Dipyrazolo[1,2-a:1',2'-d][1,2,4,5]tetrazine, tetrahydro-
|
37882-92-1 |
3 | 168.24 |
| 38-861-4 |
5-«alpha»-Pregnan-3-«beta»-16-«alpha»-diol-20-one, TMS
|
|
3 | 478.86 |
| 39-046-8 |
3-(4-Anilino-1-naphthylazo)-2,7-naphthalene disulfonic acid
|
57322-42-6 |
3 | 533.58 |
| 39-307-8 |
15,16-Epoxylabda-13(16),14-dien-8 .alpha.-ol
|
|
3 | 304.47 |
| 39-432-9 |
Isonipecotinoylisonipecotic acid, N'-(2,5-di(trifluoromethyl)benzoyl)-, ethyl ester
|
|
3 | 508.46 |
| 39-634-5 |
5-«alpha»-Pregnan-20-«beta»-ol-3-one, MO-TMS
|
|
3 | 419.72 |
| 39-730-8 |
5-«beta»-Pregnan-20-«beta»-ol-3-one, MO-TMS
|
|
3 | 419.72 |
| 39-739-9 |
2-Methyl-5-(fur-3-yl)-pent-1-en-3-ol
|
|
3 | 166.22 |
| 39-949-6 |
2,4-Imidazolidinedione, 5,5-diphenyl-1,3-bis(trimethylsilyl)-
|
|
3 | 396.64 |
| 39-983-8 |
4-Quinolinol,4-ethenyl-1-ethyldecahydro-2-methyl-(2«alpha»,4«beta»,4a«alpha»,8a«beta»)
|
38463-58-0 |
3 | 223.35 |
| 40-056-5 |
6H-Pyrido[2,1-b]quinazolin-6-one, 7,8,9,10-tetrahydro- 9-methyl
|
|
3 | 214.26 |
| 40-738-8 |
1,3-Bis(2-phenyl-1,3,4-oxadiazol-5-yl)perfluoropropane
|
5086-79-3 |
3 | 440.30 |
| 40-865-7 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,5,6-trimethyl-7,7-tetramethylene
|
|
3 | 234.30 |
| 41-014-0 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, propyl ester
|
|
3 | 359.34 |
| 41-301-1 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, tridecyl ester
|
|
3 | 465.62 |
| 41-340-8 |
1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-
|
|
3 | 253.35 |
| 41-410-0 |
allo-Cholanic acid, 3«beta»,7«beta»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 41-507-3 |
2-(2,6-Dioxo-3-piperidyl)isoindoline-1,3-dione, N-trimethylsilyl-
|
|
3 | 330.42 |
| 41-554-1 |
1-Methyl-9-[(1e)-1-propenyl]-1,9-dihydro-6h-purin-6-one
|
|
3 | 190.21 |
| 41-600-9 |
2,3,4,5,7,8,9,10,11,12-Decahydro-1H-5a,13-diaza-cyclohepta[4,5]benzo[1,2]cycloocten-6-one
|
|
3 | 246.35 |
| 41-865-6 |
5-«alpha»-Pregnan-3-«beta»,20-«alpha»,21-triol, TMS
|
|
3 | 553.05 |
| 42-134-6 |
1,2,3,4,6,7,8,9,10,11-Decahydro-5,11a-diaza-cycloocta[b]naphthalen-12-one
|
|
3 | 232.33 |
| 42-582-9 |
5«beta»-Androstan-3«alpha»,11«beta»-diol-17-one (Androsterone), MO-3-mono-TMS
|
|
3 | 407.66 |
| 42-635-0 |
5«beta»-Pregnane-3«beta»-ol-20-one, MO TMS
|
|
3 | 419.72 |
| 42-657-6 |
2,6-Pyridinedicarboxylic acid, di(1-methoxydec-4-yl) ester
|
|
3 | 507.70 |
| 42-702-5 |
2,6-Pyridinedicarboxylic acid, di(5-methoxy-3-methylpent-2-yl) ester
|
|
3 | 395.50 |
| 43-109-3 |
2,3-Diazabicyclo[2.2.2]octane,1,2,3,4-tetramethyl-,trans-
|
|
3 | 168.28 |
| 43-250-6 |
5,5'-Bis-benzylmercapto-[2,2'-azo-1,3,4-thiadiazol]
|
|
3 | 442.62 |
| 43-278-6 |
6-methyl-1,2,3,4,5,6-hexahydro-(7H)-cyclopentapyridine-7-one
|
|
3 | 153.22 |
| 43-416-2 |
3-[((1,1,3,3,5,5-Hexamethyl-5-[(3Z)-non-3-en-1-yloxy]trisiloxanyl)oxy)methyl]pyridine
|
|
3 | 455.81 |
| 43-471-1 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 2,9-dimethyl
|
|
3 | 174.20 |
| 43-527-9 |
3«alpha»,4«beta»,12«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
3 | 639.14 |
| 43-713-2 |
Methyl 5-«beta»-cholan-3-«alpha»-ol-12-one-24-oate, oxime, TMS
|
|
3 | 563.96 |
| 43-815-9 |
4-Quinolinol, 4-ethynyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«alpha»,8a«beta»)-
|
16067-80-4 |
3 | 207.31 |
| 43-820-3 |
4-Quinolinol,1,4-diethyldecahydro-2-methyl-(2«alpha»,4«beta»,4a«alpha»,8a«beta»)
|
38463-61-5 |
3 | 225.37 |
| 43-838-4 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 7-methyl
|
|
3 | 164.20 |
| 43-987-9 |
N-(5-Methylisoxazol-3-yl)-N-(trifluoroacetyl)-2,2,2-trifluoroacetamide
|
|
3 | 290.12 |
| 44-136-2 |
1-(2-Chloro-3-(1-[(cyclohexylamino)carbonyl]-2-oxohydrazino)propyl)-1-[(cyclohexylamino)carbonyl]-2-oxohydrazine
|
33024-51-0 |
3 | 416.90 |
| 44-184-9 |
Silanamine, 1,1,1-trimethyl-N-[2-[4-[(trimethylsilyl)oxy]phenyl]ethyl]-
|
54965-31-0 |
3 | 281.54 |
| 44-200-0 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N6-acetyl
|
|
3 | 208.22 |
| 44-271-2 |
(E)-1-(4-Methylphenyl)butan-1-one O-(tert-butyldimethylsilyl)oxime
|
|
3 | 291.50 |
| 44-636-7 |
allo-Cholanic acid, 3«alpha»,7«beta»,12«beta»-trihydroxy, Me-DMES
|
|
3 | 681.22 |
| 44-687-1 |
Phenothiazine, 2-chloro-10-(3-dimethylaminopropyl)-, cmpd with o-(p-hydroxybenzoyl)benzoic acid (1 to 1)
|
|
3 | 561.10 |
| 44-732-0 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-allyl-phosphorothioamidate
|
|
3 | 310.10 |
| 44-752-8 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,5,6-trimethyl-7,7-pentamethylene
|
|
3 | 248.32 |
| 44-777-1 |
Disiloxane, 1,3-bis(bromomethyl)-1,1,3,3-tetramethyl-
|
2351-13-5 |
3 | 320.17 |
| 44-863-5 |
Silane, [(3.beta.,5.alpha.)-cholest-7-en-3-yloxy]trimethyl-
|
|
3 | 458.85 |
| 44-930-0 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-isopropyl-phosphorothioamidate
|
|
3 | 312.12 |
| 45-191-0 |
O-Ethyl-O-isobutyl-S-(1,1-difluoro-3-ethylheptyl)-dithiophosphate
|
|
3 | 376.51 |
| 45-247-8 |
Silane, trimethyl[[(3«beta»,5«alpha»)-stigmastan-3-yl]oxy]-
|
55493-85-1 |
3 | 488.90 |
| 45-316-1 |
Ethyl ([1,1,3,3-tetramethyl-3-(pyridin-3-ylmethoxy)disiloxanyl]oxy)acetate
|
|
3 | 343.53 |
| 45-373-8 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 2-pentyl ester
|
|
3 | 335.44 |
| 45-414-2 |
3«beta»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, TMS
|
|
3 | 450.80 |
| 45-429-6 |
5,5-Dimethyl-2-phenoxy-1,3,2-dioxaphosphorinane 2-sulphide
|
|
3 | 258.28 |
| 45-460-1 |
3-Amino-2,3-dihydrobenzoic acid, N-dimethylaminomethylene-, methyl ester
|
|
3 | 208.26 |
| 45-501-5 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-metyl-phosphorothioamidate
|
|
3 | 284.06 |
| 45-604-1 |
7«alpha»-hydroxy, 3-oxy-4-cholenoate, methyl ester-trimethylsilyl ether
|
|
3 | 548.94 |
| 45-797-8 |
3«beta»,4«beta»,12«alpha»-trihydroxy-5«beta»-cholanoic acid acid, methyl ester-trimethylsilyl-ether derivative
|
|
3 | 639.14 |
| 45-936-3 |
3«beta»,16«alpha»-dihydroxy-5-androsten-17-one, MO-TMS, (syn,anti)
|
|
3 | 535.98 |
| 46-049-7 |
11H-Pyrido[2,1-b]quinazolin-11-one, 6,7,8,9-tetrahydro
|
|
3 | 200.24 |
| 46-138-8 |
«alpha»-D-Galactopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-
|
32166-80-6 |
3 | 541.06 |
| 46-139-7 |
4-Cyclopropyl-6-methyl-N-phenyl-N-trifluoroacetyl-pyrimidin-2-amine
|
|
3 | 321.30 |
| 46-349-4 |
3«alpha»,6«beta»,7«beta»-Trihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | 639.14 |
| 46-427-7 |
(.+/-.)-2-Phenylbutyric acid, dimethyl(3,3,3-trifluoropropyl)silyl ester
|
|
3 | 318.41 |
| 46-472-7 |
4-Quinolinol, 4-ethenyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«beta»,8a«alpha»)-
|
20431-91-8 |
3 | 209.33 |
| 46-541-0 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl
|
|
3 | 168.20 |
| 46-580-7 |
5,5-Pentamethylene-2-phenyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 258.32 |
| 46-758-0 |
Glutarimide, 3-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, semicarbazone
|
3428-71-5 |
3 | 338.40 |
| 46-896-7 |
5-«alpha»-Pregnan-3-«beta»,15 or 16-diol-20-one, MeTMS
|
|
3 | 478.86 |
| 47-116-1 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,6,7,7-tetramethyl
|
|
3 | 194.23 |
| 47-270-0 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N2,N4,N6-tris(trifluoroacetate)
|
|
3 | 454.21 |
| 47-312-3 |
5-«beta»-Cholanoic acid, 3-«alpha»,4-«beta»,12-«alpha»-trihydroxy, methyl ester, TMS
|
|
3 | 639.14 |
| 47-494-2 |
24-Nor-3«alpha»,7«alpha»-dihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | 536.93 |
| 47-524-8 |
2-Butenoic acid, 2-methyl-, 2,3,5,7a-tetrahydro-7-(hydroxymethyl)-1H-pyrrolizin-1-yl ester, [1S-[1«alpha»(Z),7a«alpha»]]-
|
723-78-4 |
3 | 237.29 |
| 47-555-4 |
5«alpha»-Androstane-3«alpha»,17«beta»-diol,bis-TMS
|
|
3 | 436.82 |
| 47-803-8 |
N-(1,2-Dimethylpropyl)-N,N'-bis(pentafluoropropionyl)-N'-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 547.41 |
| 47-980-2 |
5«alpha»-Androstane-2«beta»,3«alpha»,17«beta»-triol, TMS
|
|
3 | 525.00 |
| 48-077-4 |
2-Pyrazoline-5-one, 4,4-dimethyl-3-isopropyl-1-phenyl-
|
92292-40-5 |
3 | 230.31 |
| 48-631-8 |
2H-1,3,4-Thiadiazine, tetrahydro-2,2,4,6-tetramethyl-
|
|
3 | 160.29 |
| 48-702-9 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-cyclopentyl-phosphorothioamidate
|
|
3 | 293.70 |
| 48-877-6 |
1,2,3,4,6,7,8,9-Octahydro-pyrido[2,1-b]quinazolin-11-one
|
|
3 | 204.27 |
| 48-923-4 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 2-isopropenyl hydrazide
|
|
3 | 180.21 |
| 48-928-9 |
3«beta»,16«alpha»,17«alpha»-Tris(trimethylsiloxy)androst-5-ene
|
25876-85-1 |
3 | 522.98 |
| 48-988-3 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-methyl-phosphorothioamidate
|
|
3 | 239.61 |
| 49-434-6 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 9-methyl
|
|
3 | 164.20 |
| 49-838-8 |
5,5-Pentamethylene-2-phenyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 272.35 |
| 49-879-3 |
2-(4-Allyl-2,6-dimethoxy-phenoxy)-1 -(3,4-dimethoxy-phenyl)-propan-1-ol, TMS
|
|
3 | 460.64 |
| 49-894-6 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, pentyl ester
|
|
3 | 353.40 |
| 50-014-0 |
6-Methyl-3,5-heptadien-2-one, PFBO # 2
|
|
3 | 319.27 |
| 50-097-9 |
allo-Cholanic acid, 7«beta»,12«beta»-dihydroxy, Me-TMS
|
|
3 | 550.96 |
| 50-303-9 |
1,3-Dimethyl-5-(3-oxocyclohexen-1-yl)hexahydropyrimidine-2,4,6-trione
|
|
3 | 250.25 |
| 50-350-7 |
5-Ethyl-5-methyl-2-(1-methylethyl)-4-isobutanoyl-1,3,4-oxadiazoline
|
|
3 | 226.32 |
| 50-502-8 |
3-[((1,1,3,3-Tetramethyl-3-[(3Z)-non-3-en-1-yloxy]disiloxanyl)oxy)methyl]pyridine
|
|
3 | 381.66 |
| 50-651-3 |
benzaldehyde oxime, 2-hydroxy, 3-chloro, 5-(1,1,3,3-tetramethylbutyl)
|
|
3 | 283.79 |
| 50-920-4 |
Ergosta-5,7,9(11),22-tetraen-3«beta»-ol, TMS
|
|
3 | 466.81 |
| 51-118-4 |
3,7-Diazabicyclo[3.3.1]nonane, 3,7-dimethyl-
|
14789-33-4 |
3 | 154.25 |
| 51-206-6 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»,21-triol, MeTMS
|
|
3 | 553.05 |
|
« Previous Results
Next Results »
|